IP Library Granted Patent US 8,476,237
Granted Patent B2
US 8,476,237 · App. 13/621,618 · Granted Jul 2, 2013

Compositions and methods for treating cancer by inhibiting the secretion of microparticles

Inventors: Vincent Craig Bond (Stone Mountain, GA); Michael Powell (Douglasville, GA); Ming Bo Huang (Atlanta, GA); Syed Ali (Pinang, MY); Andrea D. Raymond (Atlanta, GA); Martin Neville Shelton (Stone Mountain, GA); Francois Jean Villinger (Decatur, GA)
Assignee: Morehouse School of Medicine
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,476,237
App. No.
13/621,618
Granted
Jul 2, 2013
Kind
B2
Abstract

Novel peptides that inhibit the release of microparticles from cells are disclosed. Also disclosed are polynucleotides encoding the peptides, expression vectors carrying the polynucleotides and methods for treating tumors using the novel peptides.

Claims (12)

1. A method for treating a tumor, comprising:

administering to a subject in need of such treatment an effective amount of a polynucleotide encoding a peptide comprising SEQ ID NO: 2, wherein said polynucleotide is capable of expressing said peptide in vivo.

2. The method of claim 1 , wherein said peptide comprises the amino acid sequence of SEQ ID NO: 3.

3. The method of claim 1 , wherein said peptide comprises at least one SEQ ID NO: 1 motif at the N-terminal.

4. The method of claim 1 , wherein said peptide comprises at least one SEQ ID NO: 1 motif at the C-terminal.

5. A method for treating a tumor, comprising:

administering to a subject in need of such treatment an effective amount of an expression vector comprising a polynucleotide encoding a peptide comprising SEQ ID NO: 2, wherein said expression vector is capable of expressing said peptide in vivo.

6. The method of claim 5 , wherein said peptide comprises the amino acid sequence of SEQ ID NO: 3.

7. The method of claim 5 , wherein said peptide comprises at least one SEQ ID NO: 1 motif at the N-terminal.

8. The method of claim 5 , wherein said peptide comprises at least one SEQ ID NO: 1 motif at the C-terminal.

9. The method of claim 5 , wherein said expression vector is a viral vector.

10. The method of claim 5 , wherein said expression vector is a non-viral vector.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2019
From: BOND, VINCENT C.; POWELL, MICHAEL; HUANG, MING BO; ALI, SYED; RAYMOND, ANDREA D.; SHELTON, MARTIN N.; VILLINGER, FRANCOIS J.
To: MOREHOUSE SCHOOL OF MEDICINE
Reel/Frame 048176/0714 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2014
From: MOREHOUSE SCHOOL OF MEDICINE
To: BOND, VINCENT C.; HUANG, MING BO; RAYMOND, ANDREA D.; VILLINGER, FRANCOIS JEAN; POWELL, MICHAEL; ALI, SYED; SHELTON, MARTIN NEVILLE
Reel/Frame 033679/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2012
From: BOND, VINCENT CRAIG; POWELL, MICHAEL; HUANG, MING BO; ALI, SYED; RAYMOND, ANDREA D.; SHELTON, MARTIN NEVILLE; VILLINGER, FRANCOIS JEAN
To: MOREHOUSE SCHOOL OF MEDICINE
Reel/Frame 029111/0605 →
Continuity (3)
Continuation 12783829 · May 20, 2010
Provisional Application 61213471 · Jun 12, 2009
Related Publication 20130018002A1 · Jan 17, 2013